Comparing costing results in across country economic evaluations: The use of technology specific purchasing power parities

Health Economics

Volumn 14, Issue 1, 2005, Pages 93-99

  Wordsworth, Sarah ^a   Ludbrook, Anne ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Comparable costing; Dialysis therapy; Exchange rates; Purchasing power parities; Technology specific conversions

Indexed keywords

ACCURACY; ARTICLE; CALCULATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; EUROPE; HEALTH CARE COST; HEALTH ECONOMICS; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; PROSPECTIVE PRICING; PURCHASING; QUESTIONNAIRE; RESOURCE MANAGEMENT;

COST-BENEFIT ANALYSIS; EUROPE; HEALTH CARE COSTS; HUMANS; KIDNEY FAILURE, CHRONIC; MODELS, ECONOMIC; QUESTIONNAIRES; RENAL DIALYSIS;

EID: 12344311195     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/hec.913     Document Type: Article

References (13)

1. Koopmanscap MR, Touw KCR, Rutten FFH. Analysis of costs and cost-effectiveness in multinational trials. Health Policy 2001; 58: 175-186.
2. Willke RJ, Glick HA, Polsky D, Schulman K. Estimating country-specific cost-effectiveness from multinational clinical trials. Health Econ 1998; 7: 481-493.
3. Jefferson T, Demicheli V, Vale L. Quality of systematic reviews of economic evaluations in health care. J Am Med Assoc 2002; 287(21): 2809-2812.
4. Schulman K, Burke J, Drummond M, Davies L, Carlsson P, Gruger J, Harris A, Lucioni C, Gisbert R, Llana T, Tom E, Bloom B, Willke R, Glick H. Resource costing for multinational neurologic clinical trials: methods and results. Health Econ 1998; 7: 629-638.
5. Drummond MF, Bloom BS, Carrin G, et al. Issues in the cross-national assessment of health technology. Int J Technol Assess Health Care 1992; 8(4): 671-682.
6. Kanavos P, Mossialos E. International comparisons of health care expenditures: what we know and what we do not know. J Health Services Res Policy 1999; 4(2): 122-125.
7. Purchasing power parities and real expenditures: 1996. Organisation for Economic Co-operation and Development (OECD), Benchmark 1999 Edition.
8. Parkin D, McGuire A, Yule B. Aggregate health care expenditures and national income: is health care a luxury good? J Health Econ 1987; 6: 109-127.
9. Gerdtham UG, Jonsson B. Conversion factor instability in international comparisons of health care expenditure. J Health Econ 1991; 10: 227-234.
10. Jefferson T, Mugford M, Gray A, Demicheli V. An exercise on the feasibility of carrying out secondary economic analyses. Health Econ 1996; 5: 155-165.
11. Goeree R, Gafni A, Hannah M, Myhr T, Blackhouse G. Hospital selection for unit cost estimates in multicentre economic evaluations. Does the choice of hospitals make a difference? Pharmacoeconomics 1999; 15(6): 561-572.
12. Gosden TB, Torgerson DJ. Converting international cost effectiveness data to UK prices. Br Med J 2002; 325: 275-276.
13. Khan IH, Campbell MK, Cantarovich D, et al. Survival on renal replacement therapy in Europe: is there a centre effect? Nephrol Dialysis Transplant 1996; 11: 300-307.